Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $552,413.70 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 11,581 shares of the business's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $47.70, for a total transaction of $552,413.70. Following the completion of the transaction, the chief financial officer owned 54,084 shares of the company's stock, valued at $2,579,806.80. The trade was a 17.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Oluyemi Okupe also recently made the following trade(s):

• On Monday, July 7th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $46.67, for a total transaction of $540,485.27.
• On Monday, June 23rd, Oluyemi Okupe sold 23,107 shares of Hims & Hers Health stock. The shares were sold at an average price of $47.25, for a total transaction of $1,091,805.75.
• On Wednesday, May 28th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $52.98, for a total transaction of $613,561.38.
• On Thursday, May 15th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $60.22, for a total transaction of $697,407.82.

Hims & Hers Health Trading Up 2.6%

HIMS traded up $1.29 during trading on Wednesday, reaching $51.75. 22,057,821 shares of the company's stock were exchanged, compared to its average volume of 24,058,495. Hims & Hers Health, Inc. has a one year low of $13.47 and a one year high of $72.98. The stock has a market capitalization of $11.58 billion, a PE ratio of 75.00, a price-to-earnings-growth ratio of 1.86 and a beta of 2.02. The firm has a fifty day moving average price of $53.89 and a two-hundred day moving average price of $41.45.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm had revenue of $586.01 million for the quarter, compared to analyst estimates of $535.21 million. During the same period in the previous year, the firm posted $0.05 EPS. The company's revenue for the quarter was up 110.7% compared to the same quarter last year. Sell-side analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on HIMS. UBS Group set a $30.00 target price on shares of Hims & Hers Health in a research report on Monday, June 23rd. Citigroup reaffirmed a "sell" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Piper Sandler reaffirmed a "neutral" rating and set a $39.00 price target (up from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Hims & Hers Health in a report on Wednesday, May 7th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $39.58.

Institutional Investors Weigh In On Hims & Hers Health

Institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new position in shares of Hims & Hers Health in the 4th quarter worth approximately $18,048,000. O Shaughnessy Asset Management LLC acquired a new position in shares of Hims & Hers Health in the 4th quarter worth approximately $208,000. Commonwealth Equity Services LLC lifted its position in shares of Hims & Hers Health by 111.6% in the 4th quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company's stock worth $1,424,000 after purchasing an additional 31,062 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Hims & Hers Health by 51.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock worth $417,000 after purchasing an additional 5,885 shares during the period. Finally, Amundi lifted its position in shares of Hims & Hers Health by 49.1% in the 4th quarter. Amundi now owns 12,741 shares of the company's stock worth $328,000 after purchasing an additional 4,197 shares during the period. 63.52% of the stock is owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.